Clinical Trial of Young Red Blood Cells Prepared by Apheresis
|
|
- Zoe Powell
- 5 years ago
- Views:
Transcription
1 ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 6 Copyright 1986, Institute for Clinical Science, Inc. Clinical Trial of Young Red Blood Cells Prepared by Apheresis PATRICIA PISCIOTTO, M.D.,* THOMAS KIRALY, S.B.B.,t LOIS PARADIS,f RAM M. KAKAIYA, M.D.,f LINDA RINK, R.N.,$ and HOWARD A. PEARSON, M.D.$ *Division Blood Bank and Hematology, The University o f Connecticut Health Center, Farmington, CT and tamerican Red Cross Blood Services, Connecticut Region, Farmington, CT and tdepartment o f Pediatrics, Yale-New Haven Hospital, New Haven, CT ABSTRACT Transfusion of young red blood cells (YRBC) with prolonged survival should result in increased intervals between transfusions and, therefore, decreased transfusion-associated iron loading. A prospective clinical trial comparing YRBC transfusions prepared by apheresis versus washed or frozen red cell transfusions was performed in five children with transfusion-dependent thalassemia. A total of 152 YRBC units, evaluated by reticulocyte enrichment and pyruvate kinase activity, were transfused. While a slightly longer interval between transfusions was observed during the time period of YRBC versus the time period after (30.0 ± 1.5 days versus 27.9 ± 1.1 days, respectively, p < 0.02), there was no associated decrease in mg of iron transfused per kg. The effectiveness of transfused YRBC units was less than predicted by in vitro and in vivo studies. Introduction Transfusion-induced hemochromatosis is of major concern in patients receiving chronic transfusion therapy, such as patients with thalassemia. Support with routine transfusions in these patients has resulted in the developm ent of iron o v erlo a d by th e end o f th eir first decade.9 Chelation therapy with deferoxamine,10 and splenectomy,5 to reduce transfusion requirements, provides two modalities utilized to slow the progression of iron loading and improve survival. Another approach to m inim ize the rate of iron accumulation associated with transfusions has been the use of young /86/ $00.90 Institute for Clinical Science, Inc.
2 4 7 4 P IS C IO T T O, KIRALY, P A R A D IS, KAKAIYA, R IN K, A N D P E A R S O N red cell products with prolonged survival. It has been theorized that the use of young red blood cells could extend the in terval b etw een tran sfu sion s and, therefore, reduce red cell req u irem ents.4 Based on the age-dependent density of red cells, several investigators have developed techniques to harvest young red cells from hum an donors u sin g con tin u o u s-flo w -c e n tr ifu g a tion4,12 13 or centrifugation of units of blood.2,6 A prospective clinical trial of transfusing young red blood cells prepared by a three hour apheresis procedure was conducted by the p resen t authors in patients with thalassemia to evaluate the effects on transfusion-associated iron loading. Materials and Methods B l o o d P r o d u c t s Young red blood cell units were prepared from volunteer donors by continuous-flow -centrifugation as previously described.12 All units were frozen within 24 hours of collection using a high glycerol procedure.8 Young red cell enrichment was assessed on all units prior to freezing. The parameters evaluated were reticulocyte counts and pyruvate kinase activity, an age-dependent en zym e.14 Enzym e analysis was performed after removal of w hite c e lls.1 Comparisons were made with donors pre-donation whole blood samples. The last 100 units transfused were filtered* to remove a large portion of the contaminating white blood cells prior to processing. Units were stored at 80 C until use. Washed red cells prepared by the IBM 2991 or frozen thawed deglycerolized red cells prepared by standard procedure8 were transfused during the time periods prior to and following YRBC transfusions. * Imugard IG500 filter, Terumo Co., Tokyo, Japan P a t ie n t s Five children with thalassemia major were included in the clinical trial. Four children, between the ages of 10 and 17 years had undergone splenectom y at least three years prior to initiating young red cell transfusions. One child, age two years and three months, had an intact spleen. The children had been routinely transfused at three to five week intervals with either washed red cells or frozen red cells to maintain a pre-transfusion hemoglobin of 10.0 g per dl. The four older children were also receiving chelation therapy. C l in ic a l T r ia l Units of young red cells were transfused for a minimum of six months (one child) and a maximum of nine months (three children). Transfusion requirements (designated as ml red blood cell [RBC] per kg) during the interval of young red cell administration were compared w ith e q u iv a le n t tran sfu sion periods prior to and after initiation of young red cells. Pre-transfusion hem oglobin, body weight, and ml of blood transfused were recorded for each transfusion episode, as well as any adverse reactions or intercurrent illnesses. Hem atocrit determ inations and weights were performed on all young red cell units and units of blood transfused during the succeeding period. The amount of transfused iron for each transfusion episode was calculated from the volume transfused, multiplied by the measured hematocrit and 1.08 mg iron per ml red cells. For the preceding transfusion period, a hematocrit of 67.8 percent was used based on the average hematocrit obtained on washed red cells during the transfusion period following young red cell transfusions. Statistical analysis was performed using the Student t test.
3 Results During the clinical trial of young red cells, 152 units w ith a final average hematocrit of 77.3 percent and average weight of g were transfused. Evaluation of young red cell enrichm ent showed a significant increase in product reticulocyte count and pyravate kinase (PK) activity as compared to donors predonation sam ples (table I). The final average hematocrit and weight of units transfused during the period following young red blood cells were 67.8 percent ± 7.6 and g ± 42.4, respectively. Evaluating the children as a group (table II) showed that the ml RBC per kg transfused during the period of young red cell transfusions was not statistically different from the periods prior to or after young red cell transfusions. A higher mean pre-transfusion hemoglobin was m aintained during the period of young red cell transfusions being slightly but significantly different than the mean pre-transfusion hemoglobin maintained during the time period after young red cells (p < 0.02). The m ean interval betw een transfusions, during the time period o f young red cells, was also slightly increased. Looking at the individual children (table III), in one patient (patient #3) there was a trend toward maintenance of a higher mean pre-transfusion hemoglobin in association with an increased time interval b etw een transfusions and a reduced amount of transfused iron per kg per week during the trial of YRBC. Even though there was no statistical difference observed during the different transfusion periods, the data suggest an increased survival of young red cells in this patient. Patient # 5 appeared to have a similar trend w hen com paring the transfusion period of YRBC to the period following the clinical trial. There were no associated illnesses during any of the transfusion periods that could account C L IN IC A L T R IA L O F Y O U N G B L O O D C E L L S T A B L E I Evaluation of Young Red Blood Cell (YRBC) Units Prepared for Transfusion N = 152 Donor reticulocyte count (%) 2.3 ± 0.9* Product reticulocyte count (%) 6.5 ± 2.5f P.K. activity (ratio to donor pre-donation blood sample) 1.38 ± 0.19t Product hematocrit (%)$ 77.3 ± 7.2 Product weight^ ±23.4 *Mean ± S.D. fp < compared to donor pre-donation blood sample. $Deglycerolized YRBC unit. for th e o b serv a tio n s in th e s e tw o patients. Patient # 4 developed pneumonia during the transfusion interval after the clinical trial of YRBC, necessitating an additional transfusion. This contributed to the lower mean pre-transfusion hem o globin and the increased transfused iron per kg per week observed during this time period. Patients # 1 and # 2 appeared to benefit the least during the clinical trial of YRBC. Patient # 1 was noted to have a slight but significant (p < 0.05) increase in the iron per kg per week during the interval of YRBC, as compared to the time interval prior to but not after the trial of YRBC. The patient experienced a five-day episode of fever associated with the developm ent of a rash during the transfusion period prior to YRBC. There w ere also two days of fever and sore throat associated with exposure to streptococcus during the time period of YRBC transfusions. Four of the five children receiving young red cell transfusions, which had not been filtered prior to freezing, experienced transfusion reactions. These consisted of chills and fever in three children, regardless of whether or not th ey r e ceiv ed p re-m ed ication w ith Tylenol and Benadryl. One child experienced headache and low back pain, not
4 47 6 PISCIOTTO, KIRALY, PARADIS, KAKAIYA, RINK, AND PEARSON T A B L E II Comparison of Transfusion History During Intervals of Young Red Blood Cell (YRBC) Transfusions versus Frozen or Washed Red Blood Cell Transfusions T im e P e r io d P re-y R B C YRBC T r a n s f u s i o n s T im e P e r io d P o st-y R B C Pre transfusion Hb (g/dl) 10.8 ± 0.6* 11.0 ± 0.6f 10.5 ± 0.7 Transfusion episodes Units transfused Transfusion reactions (non-hemolytic) Interval between transfusions (days) 27.6 ± ± 1.5t 27.9 ± 1.1 ml RBC per kg transfused 86.5 ± ± ± 13.9 ml iron per kg transfused 93.4 ± ± ± 14.9 *Mean ± S.D. fp < 0.02 compared to time period post-yrbc. associated with fever, on two separate occasions. The four children had previous histories of febrile transfusion reactions. The one child not experiencing reactions had no prior history of adverse reactions to transfusions. Pre-filtration of young red cell units resulted in the elimination of further transfusion reactions. Evaluation of the effects of prefiltration of 70 young red cell units showed a mean red cell recovery of 92.2 percent with an average of 79.7 percent of white cells removed. The product reticulocyte count, performed on the post filtered units, remained significantly increased compared to donors pre-donation sam- TABLE III Summary of Individual Patient Transfusion Data No. Age* (Y rs) S p le n ectom y RBC P ro d u c t PFf P re - Number Donor T r a n s fu s io n T r a n s f u s i o n s / E x p o s Hb ( g / d l ) W eeks u r e s T r a n s fu s e d ( m l/kg) mg I r o n / kg /W eek _ 1 2 3/12 No LPRBC$ _ / ÎÎ YRBCÿ / LP RBC / Yes LP RBC /40 _ YRBC / LPRBC / /12 Yes LPRBC +/ /36 _ YRBC / LPRBC / /12 Yes FRBC** + /-M /23.9 _ YRBC / FRBC / /12 Yes LPRBC /33.9 _ YRBC / LPRBC / *Age at initiation of YRBC. fdesferrioxamine. $Leukocyte Poor Red Blood Cells. Mean ± S.D. ip < 0.05, compared to transfusion period with YRBC. $Young Red Blood Cells Frozen Red Blood Cells fetf/- non-compliant.
5 pies (6.6 percent ± 2.9 percent versus 2.3 p ercen t ± 1.0 p ercen t, resp ectively). There was no effect on the ratio of the product P.K. activity compared to pre-donation samples (1.39 ± 0.21). Discussion Young red cells collected by continuo u s-flo w -c e n tr ifu g a tio n have b een shown, by radiochromium technique, to have prolonged half-life in both asplenic thalassemia major patients (47.7 days) and normal eusplenic donors (46.7 days) as compared to the measured half-life of standard frozen cells in the same individuals.4,12 Prolonged red cell radiochromium half-lifes (40 to 43.9 days) have also been reported with young red cells harvested from units of fresh w hole blood or frozen red cells, although not to the same degree as observed with young red cells obtained by continuous-flowcentrifugation.2,6 Early studies support the concept that young red cells have a longer in vivo survival and, therefore, regular transfusions of young red cell products should result in a reduction in the rate of transfusion-associated iron loading. Propper et al. rep orted a 13-day increase in the interval between transfusions in two patients transfused with young red cells prepared by apheresis over an eight m onth trial p erio d.13 Cohen et al. in 1984 reported on a one year clinical trial of young red blood cells prepared from units of fresh whole blood in six children with thalassemia major. M aintaining the same pre-transfusion hem oglobin le v e l there was a mean reduction in red cell requirement of 15.8 percent. This, however, was not sufficient to result in an increased time interval between transfusions.3 Furthermore, Marcus et al, reporting on a randomized clinical trial of young red cells prepared from fresh units of whole blood, found neither a significant reduction in the rate CLINICAL TRIAL OF YOUNG BLOOD CELLS 47 7 o f hem oglobin fall or a reduction in blood consum ption in splenectom ized patients w ith transfusion-dependent thalassemia.7 Based on our previous paired autologous chromium survival studies12 showing a mean increase of 35 percent of the observed T50Cr of young versus frozen red cells, a similar increase in the time interval required betw een transfusion would have been predicted by us. Our present data suggest that while individual patients may show a trend towards increased survival of transfused YRBC, it is less than the predicted advantage. Survival studies performed in normal adult eusplenic subjects, however, may not truly reflect the survival in individual patients with transfusion-dependent thalassemia. Early in the clinical trial, several children with previous histories of febrile tran sfu sion rea ctio n s e x p e r ie n c e d adverse reactions to the transfusions. W hether reactions resulted from the transfusion of several units of YRBC with residual antigenic m aterial resulting from breakdown of large num bers of white cells or the release of pyrogenic material is presently under investigation. Prefiltration of units to remove a large portion of white cells prior to processing elim inated further transfusion reactions. Our studies have shown that YRBC of consistent quality, based on in vitro assays, can be produced on a regular basis by apheresis. The cost of this product is expensive, being approximately 2.5 times the cost of a standard frozen cell unit and 4.5 tim es the cost of a washed cell unit. Approxim ately 1.6 YRBC units were transfused for each unit of frozen or washed cells given, adding not only to the expense of the transfusion episode, but to a greater number of donor exposures. The trial conducted by the present authors using an apheresis m ethod of
6 4 7 8 pisciorro, k i r a l y, p a r a d i s, k a k a iy a, r i n k, a n d p e a r s o n processing young red cells showed no significant clinical benefit in terms of increased interval between transfusions or decreased transfusion-associated iron loading. This does not preclude that other techniques which could produce younger cohorts of young red cells would not show some clinical benefit. Whether or not the benefit gained would justify the expense and time required to produce young red cells remains questionable. Acknowledgments The authors wish to thank the pheresis nurses of the American Red Cross Blood Services, Connecticut Region. The work was supported in part by A m erican Red Cross funds and the C onnecticut Campaign against Cooley s anemia. References 1. B e u t l e r, E., W e s t, C., and B l u m e, K. G.: The removal of leukocytes and platelets from whole blood. J. Lab. Clin. Med. «8: , B r a c e y, A., K l e i n, H. G., C h a m b e r s, S., a n d C o r a s h, L.: Ex vivo s e l e c t i v e i s o l a t i o n o f y o u n g r e d c e l l s b l o o d c e l l s u s i n g t h e IBM-2991 c e l l w a s h e r. B lo o d 6i: , C o h e n, A. R., S c h m i d t, J. M., M a r t i n, M. B., B a r n s l e y, W., a n d S c h w a r t z, E.: C l i n i c a l t r i a l o f y o u n g r e d c e l l t r a n s f u s i o n s. J. P e d i a t r. 104: , C o r a s h, L., K l e i n, H., D e i s s e r o t h, A., S h a f e r, B., R o s e n, S., B e m a n, J., G r i f f i t h, P., a n d N i e n h u i s, A.: S e l e c t i v e i s o l a t i o n o f y o u n g e r y t h r o c y t e s f o r t r a n s f u s i o n s u p p o r t o f t h a l a s s e m i a m a j o r p a t i e n t s. B l o o d 57: , G r a z i a n o, J. H., P i o m e l l i, S., H i l g a r t n e r, M., G i a r d i n a, P., K a r p a t k i n, M., A n d r e w, A., L o J a c o n o, N., and S e a m a n, C.: Chelation therapy in B-thalassemia major. III. The role of splenectomy in achieving iron balance. J. Pediatr. 99: , G r a z i a n o, J. H., P i o m e l l i, S., S e a m a n, C., W a n g, T., C o h e n, A. R., K e l l e h e r, J. E, J r., and S c h w a r t z, E.: A simple technique for preparation of young red cells for transfusion from ordinary blood units. Blood 59: , M a r c u s, R. E., W o n k e, B., B a n t o c k, H. M., T h o m a s, M. J. G., P a r r y, E. S., T a i t e, H., a n d H u e h n s, E. R.: A p r o s p e c t i v e t r i a l o f y o u n g r e d c e lls i n 48 p a t i e n t s w i t h t r a n s f u s i o n - d e p e n d e n t t h a l a s s e m i a. B r i t. J. H a e m a t o l. 60: , M e r y m a n, H. T. and H o r n b l o w e r, M.: A method for freezing and washing red blood cells using a high glycerol concentration. Transfusion i2: , M o d e l l, B.: Total management of thalassemia major. Arch. Dis. Child. 52: , M o d e l l, B., L e t s k y, E. A., F l y n n, D. M., P e t o, R., and W e a t h e r a l l, D. J.: Survival and desferrioxamine in thalassemia major. Brit. J. M. 284: , P i o m e l l i, S., S e a m a n, C., R e i b m a n, J., T y t u n, A., G r a z i a n o, J., T a b a c h n i k, N., and C o r a s h, L. : Separation of younger cells with improved survival in vivo: An approach to chronic transfusion therapy. Proc. Natl. Acad. Sci. 75: , P i s c i o t t o, P., K ir a l y, T., R o s e n, D., P a r a d i s, L., K a k a iy a, R. M., and M o r s e, E. E.: Preparation of young red cells for transfusion using the Fenwal CS 3000 cell separator. Am. J. Hematol. i7: , P r o p p e r, R. D., B u t t o n, L. N., a n d N a t h a n, D. G.: N e w a p p r o a c h e s t o t h e t r a n s f u s i o n m a n a g e m e n t o f t h a l a s s e m i a. B lo o d 55:55-60, S e a m a n, C., W y s s, S., and P i o m e l l i, S.: The decline in energetic metabolism with aging of the erythrocyte and its relationship to cell death. Am. J. Hematol. 8:31-42, 1980.
HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 5 Copyright 1985, Institute for Clinical Science, Inc. HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors
More informationReemergence of the International Normalized Ratio for the Standardization of Prothrombin Time*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. Reemergence of the International Normalized Ratio for the Standardization of Prothrombin
More informationAnalysis of Two Types of Granulocyte Transfusions in Patients with Acute Leukemia and Septicemia
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Analysis of Two Types of Granulocyte Transfusions in Patients with Acute Leukemia and Septicemia
More informationComponents of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?
Components of Blood Formed elements Cells Erythrocytes (RBCs) Leukocytes (WBCs) Thrombocytes (platelets) Plasma 90% water 10% solutes Proteins, clotting factors 1 What can we give? Whole blood Packed RBC
More informationGUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS
CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.
More information2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?
Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching
More informationA group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells.
Thalassemia A group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells. Types of Thallasemia 1) Thalassemia trait 2)
More informationTRANSFUSION REACTIONS
14 TRANSFUSION REACTIONS 14.1 INTRODUCTION Transfusion of blood and blood products are reported to cause reactions during or after procedure specially in patients who receive multiple transfusions. These
More informationSensitivity of Serum Fructosamine in Short Term Glycemic Control
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Sensitivity of Serum Fructosamine in Short Term Glycemic Control
More informationBlood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?
What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to
More informationJovona Powelson, B.S. MLT (ASCP) Director of Laboratories
Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories Blood Products From the Donor to You Objectives Deliver a brief virtual tour of a blood center. Describe the number of donors needed to meet the
More information#2 - Hematology I Blood Typing
#2 - Blood Typing Objectives: Learn the theory behind blood typing Be able to perform simulated blood typing and analysis Understand the theory behind blood transfusions (donors and recipients) Observe
More informationBlood Components & Indications for Transfusion. Neda Kalhor
Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets
More informationWhole Blood Viscosity in Beta Thalassemia Minor
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 4 Copyright 1992, Institute for Clinical Science, Inc. Whole Blood Viscosity in Beta Thalassemia Minor JAMES P. CROWLEY, M.D.t, JACLYN B. M ETZGER,
More informationWhat is an Apheresis Donation?
What are Platelets? Platelets are colorless, irregularly shaped bodies found in blood. The primary role of platelets is to prevent bleeding in injured blood vessel walls by forming an aggregate at the
More informationCELLULAR THERAPY QUIZ. Correct answers and rationale
CELLULAR THERAPY QUIZ Correct answers and rationale In January 2018, registered cellular therapy (CT) facilities were asked to participate in the quiz to determine the educational needs of the users regarding
More informationBLOOD DONORS AND THALASSEMIA
FIODS 3 rd International Seminar Lucca, 5 th October 2013 BLOOD DONORS AND THALASSEMIA Dr. Giancarlo Ferrazza, M.D. U.O.C. di Immunoematologia e Medicina Trasfusionale Policlinico Umberto I - Sapienza
More informationwith their viability and resistance to hemolysis ,19
A n n a l s o f C l i n i c a l L a b o r a t o r y S c i e n c e, V o l. 1, N o. 2 C o p y r i g h t 1 9 7 1, I n s t i t u t e f o r C l i n i c a l S c i e n c e In Vitro Parameters of the Integrity
More informationRisks and Benefits of Blood Transfusions. Objectives. Red Cells (Erythrocytes) Understand the following:
Risks and Benefits of Blood Transfusions Patient and Family Conference Aplastic Anemia & MDS International Foundation July 10-12 th, 2009 Indianapolis, Indiana Susan M. Carson RN, MSN, CPNP Childrens Hospital
More informationE levated Prolactin Level in Prostates with Latent Carcinoma
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. E levated Prolactin Level in Prostates with Latent Carcinoma RYUICHI YATANI, M.D.,* ITSUO
More informationTransfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium
Transfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium Annie Winkler MD Assistant Professor, Emory University Department of Pathology
More informationTransfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service
Transfusion 2004: Current Practice Standards Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Massive Transfusion Protocol (MTP) When should it be activated? Massive bleeding i.e. loss of one blood
More informationBlood Product Modifications: Leukofiltration, Irradiation and Washing
1. Leukocyte Reduction Definitions and Standards: o Process also known as leukoreduction, or leukofiltration o Applicable AABB Standards, 25th ed. Leukocyte-reduced RBCs At least 85% of original RBCs
More informationControlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in Advanced Parkinson s Disease
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 2 Copyright 1989, Institute for Clinical Science, Inc. Controlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in
More information/83/ $01.20 Institute for Clinical Science, Inc.
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 4 1983, Institute for Clinical Science, Inc. Hematologic Findings in Southeast Asian Immigrants with Particular Reference to Hemoglobin E *t$ W ILLIAM
More informationResponse of Red Blood Cell Control Materials to Altered Testing Conditions
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 1 Copyright 1988, Institute for Clinical Science, Inc. Response of Red Blood Cell Control Materials to Altered Testing Conditions MARK E. SHERMAN,
More informationBlood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD
Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have
More informationRed cell disorder. Dr. Ahmed Hasan
Red cell disorder Dr. Ahmed Hasan Things to be learned in this lecture Definition and clinical feature of anemia. Classification of anemia. Know some details of microcytic anemia Question of the lecture:
More informationTransfusion Management of IgA deficiency. Emily Coberly, MD Medical Director, Transfusion Services University of Missouri Columbia
Transfusion Management of IgA deficiency Emily Coberly, MD Medical Director, Transfusion Services University of Missouri Columbia Our patient 63 year-old female with a duodenal stricture who was admitted
More informationThe Effect of Metal Chelators on Lipid Peroxidation in Irradiated Erythrocytes
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 6 Copyright 1992, Institute for Clinical Science, Inc. The Effect of Metal Chelators on Lipid Peroxidation in Irradiated Erythrocytes JOSEPH A. KNIGHT,
More informationWRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events
WRHA Blood Conservation Service WRHA Transfusion Practice Committee TEAM TRANSFUSION Differential Diagnosis of Adverse Events MANITOBA ADVERSE EVENT REPORTING SYSTEM DATA FLOW REACTION Physician orders
More informationBlood/Blood Component Utilization and Administration Annual Compliance Education
Blood/Blood Component Utilization and Administration Annual Compliance Education This course contains annual compliance education necessary to meet compliance and regulatory requirements. Instructions:
More informationHydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease
Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease A Pocket Guide for the Clinician Susan E. Creary, MD, MSc 1 John J. Strouse, MD, PhD 2 1 The Ohio State University School of
More informationInterpretation of Breathalyser Results for Medico-Legal Purposes
Interpretation of Breathalyser Results for Medico-Legal Purposes - AN INVESTIGATION OF THE BLOOD ALCOHOL CONCENTRATION OF SUBJECTS MONITORED IN A SERIES OF CONTROLLED DRINKING EXPERIMENTS I. E. C. Cameron3
More informationLONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey. Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France
LONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Ercan Ok Divis ion of N ephrology E ge U nivers ity
More informationCurrent Trends in the Management of Homozygous ß-Thalassemia
Review Article Current Trends in the Management of Homozygous ß-Thalassemia From the Yale University School of Medicine, New Haven. Howard A. Pearson, MD Address reprint requests and correspondence to
More informationHemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 6 Copyright 1993, Institute for Clinical Science, Inc. Hemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
More informationWhat You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014
What You Need to Know About Blood Transfusion Elianna Saidenberg May 2014 Objectives Why your doctor might order transfusion therapy Where does the blood come from The beginning of your transfusion Consent
More informationUKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY
Lexington, KY Page 1 of 13 Affected Sites: Enterprise Chandler X Good Samaritan I. PRINCIPLE: The UK Good Samaritan Hospital is dedicated to serve the patients with safe, high quality blood products and
More informationEvaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Evaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates JON ATH AN
More informationADULT TRANSFUSION GUIDELINES ORDERED COMPONENT
ADULT TRANSFUSIN GUIDELINES RDERED Packed red cells (RBCs) RBCs, WBCs, platelets & plasma (minimal) Increase red cell mass and oxygen carrying capacity; generally indicated when Hgb is 7 gm or Hct 21 unless
More informationBMTCN REVIEW COURSE PRE-TRANSPLANT CARE
BMTCN REVIEW COURSE PRE-TRANSPLANT CARE Jennifer Shamai MS, RN, AOCNS, BMTCN Professional Practice Leader Department of Clinical Practice And Professional Education Click How to edit the Master Experts
More informationThyroid Screening in the Newborn: Utah Experience
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 1 Copyright 1983, Institute for Clinical Science, Inc. Thyroid Screening in the Newborn: Utah Experience BRUCE A. BUEHLER. M.D.,* MELVIN J. GORTATOUSKI,
More informationEffective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)
1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory
More informationCOMPONENT SECTION MANUAL THE PROCEDURE FOR THE PREPARATION OF WHOLE BLOOD FOR NEONATAL EXCHANGE TRANSFUSION
SOP from a Massachusetts BLOOD BANK DONOR/TRANSFUSION SERVICE COMPONENT SECTION MANUAL THE PROCEDURE FOR THE PREPARATION OF WHOLE BLOOD FOR I. PURPOSE: To describe the steps necessary to prepare reconstituted
More informationA Hemoglobin A1C Immunoassay Method Not Affected By Carbamylated Hemoglobin*
ANNALS O F CLIN ICA L AND LABORATORY SCIEN CE, Vol. 25, No. 1 Copyright 1995, Institute for Clinical Science, Inc. A Hemoglobin A1C Immunoassay Method Not Affected By Carbamylated Hemoglobin* ANDREA M.
More informationEffects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task
Effects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task R obert S. K ennedy*, Janet J. Turnage*, D eborah L. H arm ** and Julie M. Drexler*** *Essex Corporation,
More informationMorphological Components and Blood Serum Proteins in Hybrids of the Skunk and Ferret During the Postnatal Period
A C T A THERIOLOGICA V ol. 23, 15: 269 276, 1978 Morphological Components and Blood Serum Proteins in Hybrids of the Skunk and Ferret During the Postnatal Period H enryk BIEGUSZEWSKI & Roman SZYMECZKO
More informationM. Velizarova, T. Yacheva and K. Tzatchev Department of Clinical Laboratory and Clinical Immunology, MU Sofia
50, 48, 2012, 3, ADVIA 2120.,.., ANALYSIS OF DIAGNOSTIC RED CELL CYTOGRAMS, GENERATED BY THE ADVIA 2120 HEMATOLOGY ANALYZER M. Velizarova, T. Yacheva and K. Tzatchev Department of Clinical Laboratory and
More informationH yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 4 Copyright 1985, Institute for Clinical Science, Inc. H yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume Use
More informationTransfusion Medicine Best Practices: Indications for Blood Components
Transfusion Medicine Best Practices: 1.0 Policy Statements 1.1 Regional Health Authorities (RHAs) shall develop policies, processes and procedures for ordering, distribution, storage, transfusion and administration
More informationErythropoietin stimulates stem cells in the bone marrow to produce more red blood cells.
NAME: HR: RED GOLD WEBSITE WORKSHEET The following website has great information on the biology and history of blood. You will be divided into groups to work on individual sections of the worksheet. You
More informationAntithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 20, No. 4 Copyright 1990, Institute for Clinical Science, Inc. Antithymocyte Serum Suppression of Immunity in Mice Immunized to Leishmania donovani* G.
More informationPediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency.
Pediatrics Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment See online here Pyruvate kinase deficiency is an inherited metabolic disorder characterized by a deficiency in the enzyme "pyruvate kinase"
More informationA Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
ANNALS O F CLINICAL AND LABORATORY SC IEN CE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
More informationRENAL & HEMATOLOGY EMERGENCIES JEFF SIMONS B.S. F-PC
RENAL & HEMATOLOGY EMERGENCIES JEFF SIMONS B.S. F-PC GOALS Overview of renal system anatomy / physiology Discuss common medical / trauma renal issues Identify associated assessment keys GOALS Introduction
More informationTransient Reticulocytopenia in Viral Illness
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 3 Copyright 1982, Institute for Clinical Science, Inc. Transient Reticulocytopenia in Viral Illness JAMES J. BIEMER, M. D. and FRANK M. TAYLOR III,
More informationProblems in the Diagnosis of Transferase and Galactokinase D eficient Galactosemia
AN NALS O F CLINICA L A N D LABORATORY SC IENCE, Vol. 10, No. 1 Copyright 1979, Institute for Clinical Science, Inc. Problems in the Diagnosis of Transferase and Galactokinase D eficient Galactosemia M
More informationIron depletion in frequently donating whole blood donors. B. Mayer, H. Radtke
Iron depletion in frequently donating whole blood donors B. Mayer, H. Radtke Iron: relevance oxygen-transporting and storage proteins hemoglobin and myoglobin iron-containing centers in many enzymes mitochondrial
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationThe Child with a Hematologic Alteration
47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct
More informationA prospective clinical trial of autologous TARGT prolonged EPO secretion showed EPO-independence in EPO-dependent ESRD patients
A prospective clinical trial of autologous TARGT prolonged EPO secretion showed EPO-independence in EPO-dependent ESRD patients September 19, 2015 TARGT TM (Transduced Autologous Restorative Gene Therapy)
More informationAn Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD
Harold Alvarez, MD Objectives Explain the etiology of platelet refractoriness Discuss the different types of platelet refractoriness Describe how platelet refractoriness is diagnosed Discuss different
More informationUnit 5: Blood Transfusion
Unit 5: Blood Transfusion Blood transfusion (BT) therapy: Involves transfusing whole blood or blood components (specific portion or fraction of blood lacking in patient). Learn the concepts behind blood
More informationScreening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions
Screening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions C arl A. S o d e r str o m, M.D.,1 P a tricia C. D isc h in g e r, P h.d.,2 G ord on S. S m ith, M.D.3
More informationOneMatch Stem Cell and Marrow Network. Training Guide
OneMatch Stem Cell and Marrow Network Training Guide What is OneMatch all about? OneMatch is a Canadian Program that matches and coordinates the collection of stem cells from potential donors to help save
More informationSTUDIES OF R H E U M A T IC D IS E A S E 1. Ross L. G a u l d a n d F r a n c e s E. M. R ea d 2
STUDIES OF R H E U M A T IC D IS E A S E 1 I I I. F A M I L I A L A S S O C IA T IO N A N D A G G R E G A T IO N I N R H E U M A T I C D IS E A S E Ross L. G a u l d a n d F r a n c e s E. M. R ea d 2
More informationBlood and Marrow Transplant (BMT) for Sickle Cell Disease
Blood and Marrow Transplant (BMT) for Sickle Cell Disease Rhiannon is now cured of sickle cell disease after BMT. Blood and marrow transplant (BMT) is a proven cure for sickle cell disease. This handbook
More informationDr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL
Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL CASE HISTORY 4 yrs old previously well boy Born to 2 nd degree consanguinity Fever x 5 days
More informationHaemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD
Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD Introduction is the iron-containing oxygen transport metalloprotein in the red blood cells Hemoglobin in the blood carries oxygen from the respiratory organs
More informationA Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase and Hydroxyproline Assays
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright 1978, Institute for Clinical Science A Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase
More informationBLOOD. Dr. Vedat Evren
BLOOD Dr. Vedat Evren Blood Liquid suspension of formed elements Blood = Blood cells + plasma Plasma = Coagulation factors + serum Cells = Erythrocytes + Leukocytes + Thrombocytes 8 % of the total body
More informationTypes of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014
Types of Anaemias and their Management S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Objectives At the end of the presentations participants should be able to: 1. Define
More informationWhat are the four parts of blood and what are their main functions?
1/24/19 Bell Ringer: Please COPY THE QUESTION in your notebook and date it below your drawing from yesterday: THEN ANSWER IT IN WRITING IN YOUR NOTEBOOK FOR POINTS. What are the four parts of blood and
More informationHigh Hemoglobin F in a Saudi Child Presenting with Pancytopenia
Case Report imedpub Journals http://www.imedpub.com Journal of Pediatric Care ISSN 2471-805X DOI: 10.21767/2471-805X.100002 High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Abstract Saudi
More informationImproved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Improved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant ALAN B. LOREN,
More informationPathological Evaluation of WR Administered Orally in Irradiated and Non-Irradiated Male Mice
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 3 Copyright > 1992, Institute for Clinical Science, Inc. Pathological Evaluation of WR-151327 Administered Orally in Irradiated and Non-Irradiated
More informationWhen to Transfuse Blood in Sickle Cell Disease?
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 5 Copyright 1994, Institute for Clinical Science, Inc. When to Transfuse Blood in Sickle Cell Disease? Lessons from Jehovah s Witnesses*! EUGENE
More informationBlood Typing OBJECTIVES
OBJECTIVES Selected Blood Tests 1. Define and understand the relationships between the key terms listed in this exercise. 2. Use the appropriate antisera to determine an unknown blood type. 3. Interpret
More informationProblems with Outliers in Breath Alcohol Testing
Problems with Outliers in Breath Alcohol Testing Jo c h e n W ilske Blood alcohol concentration (BAC) and impairment o f driving skills are related so closely, that statutory drink-drive limits are accepted
More informationBoot Camp Transfusion Reactions
Boot Camp Transfusion Reactions Dr. Kristine Roland Regional Medical Lead for Transfusion Medicine, VCH Objectives By the end of this session, you should be able to: Describe in common language the potential
More informationCatheterSeptotomy in Type B Aortic
CatheterSeptotomy in Type B Aortic Dissection Ram on Berguer Juan Parodi University ofmichigan The Hypothesis In a dissected aorta the lum en w ith the higher outflow resistance w ilhave the higherm ean
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
More informationTRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES
TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES Chowdhury FS 1, Biswas J 2, Siddiqui MAE 3, Hoque MM 4, Adnan SK 5 Abstract: Context: Blood transfusion is a life saving procedure.
More information2. Does the patient have a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP)?
Pharmacy Prior Authorization MERC CARE (MEDICAID) Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax
More informationTransfusion Reactions. Directed by M-azad March 2012
Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal
More informationTransfusion Therapy & Safety. Mary Grabowski, RN, BSN, BSIA Transfusion Safety Officer PSONEC Fundamentals September, 2015
Transfusion Therapy & Safety Mary Grabowski, RN, BSN, BSIA Transfusion Safety Officer PSONEC Fundamentals September, 2015 Topics Blood Components Special Processing/Attributes Irradiation Leukoreduction
More informationChest diseases Hospital Laboratory Hematology Practice guidelines
Chest diseases Hospital Laboratory Hematology Practice guidelines Title RBCs transfusion in Adults SOP Code Policy Owner Hematology Unit Section Hematology Prepared By Dr. Taher Ahmed Abdelhameed Issuing
More informationTRANSFUSION REACTION EVALUATION
Lab Dept: Test Name: Transfusion Services TRANSFUSION REACTION EVALUATION General Information Lab Order Codes: Synonyms: CPT Codes: Test Includes: TRXR Transfusion Complication Workup; Hemolytic reaction
More informationLifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.
LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual
More informationLipid Peroxidation in Platelet Concentrates: Effects of Leukocyte Removal by Filtration*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 1 Copyright 1994, Institute for Clinical Science, Inc. Lipid Peroxidation in Platelet Concentrates: Effects of Leukocyte Removal by Filtration* JOSEPH
More informationBridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting
Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Kim Smith-Whitley, MD Director Comprehensive Sickle Cell Center The Children s
More informationRationale for RBC Transfusion in SCD
Rationale for RBC Transfusion in SCD Dilution of HgbS-containing RBCs via the addition of HgbA-containing cells from the blood of normal donors Suppression of erythropoietin release caused by the rise
More informationChapter 13 The Blood
Chapter 13 The Blood Copyright 2015 Wolters Kluwer Health Lippincott Williams & Wilkins Overview Key Terms agglutination erythrocyte lymphocyte albumin fibrin megakaryocyte anemia hematocrit monocyte antigen
More informationPatient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016
Patient Blood Management Marisa B. Marques, MD UAB Department of Pathology November 17, 2016 Learning Objectives Upon completion of the session, the participant will: 1) Differentiate between the various
More informationHEMOGLOBIN CONTENT OF PLASMA OF BANKED BLOOD, AND OF SERUM OF PATIENTS WITH TRANSFUSION REACTIONS*
HEMOGLOBIN CONTENT OF PLASMA OF BANKED, AND OF SERUM OF PATIENTS WITH TRANSFUSION REACTIONS* MORTON GROVJE-RASMUSSEN, M.D., AND LAMAR SOUTTER, M.D. From the Blood Bank of the Massachusetts General Hospital,
More informationHemoglobin Alc and Diabetes Mellitus
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 10, No. 2 Copyright 1980, Institute for Clinical Science, Inc. Hemoglobin Alc and Diabetes Mellitus HYMAN ROCHM AN, P h.d., M.D. Department o f Pathology,
More informationDiagnostic Approach to Patients with Anemia
J KMA Special Issue Diagnostic Approach to Patients with Anemia Seonyang Park, MD Department of Internal Medicine, Seoul National University College of Medicine E mail : seonpark@snu.ac.kr J Korean Med
More informationWHICH OF THE FOLLOWING COMPRISE A
HEMATOLOGY QUESTION REVIEW WHICH OF THE FOLLOWING COMPRISE A LOGICAL SEQUENCE OF VESSELS AS BLOOD EXITS THE HEART? a. capillaries; arteries; veins b. veins; capillaries; arteries c. arteries; capillaries;
More informationWhat can we learn from cryopreserved blood cells?
What can we learn from cryopreserved blood cells? Andreas Sputtek Universitätsklinikum Hamburg-Eppendorf Inst. f. Transfusionsmedizin Hamburg, Germany http://www.sputtek.de Plenary Lecture (Definition)
More information